Literature DB >> 2192096

Sexual transmission efficiency of hepatitis B virus and human immunodeficiency virus among homosexual men.

L A Kingsley1, C R Rinaldo, D W Lyter, R O Valdiserri, S H Belle, M Ho.   

Abstract

The relative sexual transmission efficiency of hepatitis B virus (HBV) and human immunodeficiency virus type 1 (HIV-1) was investigated by a prospective study of homosexual men in Pittsburgh, Pa, from the Multicenter AIDS Cohort Study. During the 30-month follow-up, 19.8% and 7.8% of the initially seronegative HBV and HIV-1 groups were estimated to seroconvert to HBV and HIV-1, respectively. The significantly higher cumulative HBV seroconversion rate occurred despite a much lower prevalence of hepatitis B carriers (7% were hepatitis B surface antigen positive) compared with HIV-1 carriers (22% were HIV-1 antibody positive). The sexual exposure profile of HBV and HIV-1 seroconverters was similar during the 6 months prior to seroconversion, supporting the link between anal intercourse and acquisition of either infection. However, insertive, not receptive, anal intercourse was the major risk factor identified for HBV seroconversion, suggesting that transurethral exposure is an important mode of transmission. These data suggest that HBV is transmitted 8.6-fold more efficiently than HIV-1 among homosexual men studied and underscore the benefits of both HBV immunization and use of condoms during intercourse to prevent HBV infection.

Entities:  

Mesh:

Year:  1990        PMID: 2192096

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  23 in total

Review 1.  Understanding correlates of hepatitis B virus vaccination in men who have sex with men: what have we learned?

Authors:  L J Yee; S D Rhodes
Journal:  Sex Transm Infect       Date:  2002-10       Impact factor: 3.519

2.  Association of hepatitis B virus infection with other sexually transmitted infections in homosexual men. Omega Study Group.

Authors:  R S Remis; A Dufour; M Alary; J Vincelette; J Otis; B Mâsse; B Turmel; R LeClerc; R Parent; R Lavoie
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

Review 3.  Oral sex and the transmission of viral STIs.

Authors:  S Edwards; C Carne
Journal:  Sex Transm Infect       Date:  1998-02       Impact factor: 3.519

4.  Hepatitis B as a Sexually Transmitted Disease: Effective measures against this common STD.

Authors:  B A Morris
Journal:  Can Fam Physician       Date:  1992-11       Impact factor: 3.275

Review 5.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28

6.  Mannose binding lectin genotypes influence recovery from hepatitis B virus infection.

Authors:  Chloe L Thio; Timothy Mosbruger; Jacquie Astemborski; Spencer Greer; Gregory D Kirk; Stephen J O'Brien; David L Thomas
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 7.  The repertoire of human efforts to avoid sexually transmissible diseases: past and present. Part 2: Strategies used during or after sex.

Authors:  B Donovan
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

8.  Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.

Authors:  Chloe L Thio; Jacquie Astemborski; Arman Bashirova; Timothy Mosbruger; Spencer Greer; Mallory D Witt; James J Goedert; Margaret Hilgartner; Audrey Majeske; Stephen J O'Brien; David L Thomas; Mary Carrington
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infection.

Authors:  T Wölfel; P Schirmacher; J Schlaak; P Knolle; H P Dienes; W Dippold; K H Meyer zum Büschenfelde; G Gerken
Journal:  Clin Investig       Date:  1994-12

10.  Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.

Authors:  Chloe L Thio; Timothy L Mosbruger; Richard A Kaslow; Christopher L Karp; Steffanie A Strathdee; David Vlahov; Stephen J O'Brien; Jacquie Astemborski; David L Thomas
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.